Prognostic implications of unbiased molecular categorization in kidney disease
Kidney International · 2024
DOI: 10.1016/j.kint.2024.02.019 ↗Kurz gefasst
Kommentar in der Zeitschrift Kidney International, 2024. Verfasst von Michael T Eadon. Beteiligte Einrichtung: Division of Nephrology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Electronic address: meadon@iupui.edu. Hauptthemen laut MEDLINE: Disease Progression, Kidney, Proteomics, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: Indiana University School of Medicine.
Abstract (Originalsprache)
In this commentary, a novel approach to the reclassification of chronic kidney disease is reviewed. In the revisited study, the investigators identify 4 distinct subtypes of kidney disease derived from an unbiased self-organizing map of transcriptomic data from kidney biopsy samples. These molecular subtypes then are characterized by biologic cell processes, clinical and histopathologic features, urinary proteomics, and disease progression. The strengths and limitations of the self-organizing map approach are assessed; the prognostic, diagnostic, and therapeutic implications are considered briefly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Electronic address: meadon@iupui.edu.
Förderung
- Indiana University School of Medicine
Zitieren
APA
Eadon, M. T. (2024). Prognostic implications of unbiased molecular categorization in kidney disease. Kidney International. https://doi.org/10.1016/j.kint.2024.02.019
Vancouver
Eadon MT. Prognostic implications of unbiased molecular categorization in kidney disease. Kidney International. 2024. doi:10.1016/j.kint.2024.02.019
BibTeX
@article{Eadon2024,
author = {Eadon, Michael T},
title = {Prognostic implications of unbiased molecular categorization in kidney disease},
journal = {Kidney International},
year = {2024},
doi = {10.1016/j.kint.2024.02.019}
}
EUVIMED